New drug candidates for treatment of atypical meningiomas: An integrated approach using gene expression signatures for drug repurposing

Overview of attention for article published in PLOS ONE, March 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (64th percentile)
Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

twitter: 7 X users

Readers on

mendeley: 60 Mendeley

So far, Altmetric has seen 8 X posts from 7 X users, with an upper bound of 16,207 followers.

RT @MeningiomaBot: New drug candidates for treatment of atypical #meningiomas: An integrated approach using gene expression signatures for…

New drug candidates for treatment of atypical #meningiomas: An integrated approach using gene expression signatures for drug repurposing. https://t.co/gTCJumsmvt

New drug candidates for treatment of atypical meningiomas: An integrated approach using gene expression signatures for drug repurposing. https://t.co/2TZOjNgnoq

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 4 additional X posts.